Taysha Gene Therapies Inc... (TSHA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

2.02

-1.70%

After-hours Dec 13, 2024, 07:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	15.45M	2.50M	-	-	-
Cost of Revenue	-	2.49M	492.00K	9.00K	-
Gross Profit	15.45M	15.00K	-492.00K	-9.00K	-
Operating Income	-72.44M	-162.45M	-173.27M	-43.00M	-1.11M
Interest Income	3.57M	249.00K	172.00K	49.00K	-
Pretax Income	-111.57M	-166.01M	-174.52M	-60.01M	-1.11M
Net Income	-111.57M	-169.58M	-175.46M	-43.00M	-1.11M
Selling & General & Admin	30.05M	37.36M	41.32M	11.11M	128.00K
Research & Development	56.78M	91.17M	131.94M	31.89M	987.00K
Other Expenses	1.06M	-18.00K	-	-17.03M	-
Operating Expenses	87.89M	128.53M	173.27M	43.00M	1.11M
Interest Expense	5.00M	3.80M	1.43M	28.00K	-
Selling & Marketing Expenses	-	-	-	-	-384.00K
Cost & Expenses	87.89M	128.53M	173.27M	43.00M	1.11M
Income Tax	-	3.57M	936.00K	-17.01M	-4.46M
Shares Outstanding (Basic)	116.12M	43.95M	37.65M	17.67M	36.99M
Shares Outstanding (Diluted)	116.12M	43.95M	37.65M	17.67M	36.99M
EPS (Basic)	-0.96	-3.86	-4.66	-2.43	-0.03
EPS (Diluted)	-0.96	-3.86	-4.66	-2.43	-0.03
EBITDA	-105.20M	-159.73M	-172.78M	-42.99M	-
Depreciation & Amortization	1.37M	2.49M	492.00K	9.00K	4.46M